Results 1 - 20 of 61 in Impax Laboratories
-
Lilly sues generic-drug makers over Cymbalta
... of the antidepressant Cymbalta drug. Bloomberg reports that Lilly also accused rivals Wockhardt Ltd., Impax Laboratories Inc. and Cobalt Laboratories Inc. in separate lawsuits of trying to manufacture a drug that infringes on Lilly's patent, which ...
Comment?
-
Lilly sues generic-drug makers over Cymbalta
... of the antidepressant Cymbalta drug. Bloomberg reports that Lilly also accused rivals Wockhardt Ltd., Impax Laboratories Inc. and Cobalt Laboratories Inc. in separate lawsuits of trying to manufacture a drug that infringes on Lilly's patent, which ...
Comment?
-
IMPAX to Webcast Presentation to Analysts on November 17, 2008
IMPAX Laboratories, Inc. today announced that Arthur A. Koch, Jr., its senior vice president and chief financial officer, will provide a review of the information contained in the Company ' s Form 10 ...
Comment?
-
Generic drug maker Impax makes impact with filings
It's not that Hayward generic drug maker Impax Laboratories Inc. ever physically left; the 759-employee company just didn't file key reports with Securities and Exchange Commission regulators.
Comment?
-
Impax earns $18.5M in first half of 2008
Generic drug maker Impax Laboratories Inc. reported a profit of $18.5 million for the first six months of 2008.
Comment?
-
IMPAX Files Form 10 Registration Statement
IMPAX Laboratories, Inc. today announced the completion of the audits of the Company ' s 2004 through 2007 financial results and that it has filed a Form 10 registration statement with the Securities and ...
Comment?
-
... a lesson on prior art burden shifting, and the difference between anticipatory and enabling prior art. Impax Laboratories v. Aventis Pharmaceuticals (CAFC 2007-1513 ) An issued patent enjoys a presumption of validity. Impax Labs. , 468 F.3d at 1378. ...
Comment?
-
IMPAX to Present at UBS 2008 Global Life Sciences Conference
IMPAX Laboratories, Inc. today announced that Arthur A. Koch, Jr., its senior vice president and chief financial officer, will present at the UBS 2008 Global Life Sciences Conference on Thursday, September ...
Comment?
-
HAYWARD--- IMPAX Mourns the Death of Dr. Charles Hsiao, Co-Founder and Chairman
IMPAX Laboratories, Inc. sadly reports the recent death of Charles Hsiao, Ph.D., its long-time Chairman.
Comment?
-
IMPAX Mourns the Death of Dr. Charles Hsiao, Co-Founder and Chairman
IMPAX Laboratories, Inc. sadly reports the recent death of Charles Hsiao, Ph.D., its long-time Chairman.
Comment?
-
AstraZeneca Wins Prilosec Appeal
The U.S. Court of Appeals for the Federal Circuit has upheld the ruling of a District Court in favor of AstraZeneca in a patent infringement case against Apotex Corp and Impax Laboratories over its heartburn ...
Comment?
-
Industry Insider: Personalized medicine studied
... A federal appeals court upheld AstraZeneca's patents on Prilosec, a ruling that blocks generic drugmakers Impax Laboratories and Apotex from launching copycat versions of the heartburn tablet in the United States. The ruling by the U.S. Court of ...
Comment?
-
... patent. Astra's patents stood the test. In re Omeprazole Patent Litigation; Astrazeneca v. Apotex and Impax Laboratories (CAFC 2007-1414, -1416, -1458, -1459 ) Patents in suit: 4,786,505 & 4,853,230 . This is the "second wave" of a hard-fought ...
Comment?
-
Impax sued over generic painkiller
A unit of Johnson & Johnson, the world's largest maker of health-care products, sued generic drugmaker Impax Laboratories Inc.
Comment?
-
Impax sued over generic painkiller
A unit of Johnson & Johnson, the world's largest maker of health-care products, sued generic drugmaker Hayward-based Impax Laboratories Inc., alleging infringement of a patent for the painkiller Ultram ER.
Comment?
-
IMPAX Sued Based on ANDA for Generic Ultram(R) ER
IMPAX Laboratories, Inc. today announced Purdue Pharma Products L.P. , Napp Pharmaceutical Group Ltd.
Comment?
-
IMPAX's reports positive results from Phase III study of IPX056
7 August 2008 - IMPAX Laboratories, a technology based speciality pharmaceutical company engaged in the development of controlled-release and specialty generics and brand products, announced today (7 August) that IPX056, an investigational ...
Comment?
-
Impax announces positive Phase III trial of spasticity treatment
Impax Laboratories Inc. on Thursday said a Phase III study of a treatment for spasticity in multiple sclerosis patients had been successful.
Comment?
-
IMPAX to Present at Bank of America 2008 Specialty Pharmaceuticals Conference
IMPAX Laboratories, Inc. today announced that Arthur A. Koch, Jr., its senior vice president and chief financial officer, will present at the Bank of America 2008 Specialty Pharmaceuticals Conference on ...
Comment?
-
IMPAX Sued Based on ANDA Amendment for Additional Dosage Forms of Generic Opana(R) ER
HAYWARD, Calif. - IMPAX Laboratories, Inc. today announced Endo Pharmaceuticals, Inc.
Comment?
Impax Laboratories Forum
Most Popular